| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 05/18/2007 | CA2629258A1 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom |
| 05/18/2007 | CA2627426A1 Carbocyclic fused cyclic amines as inhibitors of the coagulation factor xa |
| 05/18/2007 | CA2627263A1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor |
| 05/18/2007 | CA2627260A1 2-(benzimidazol-1-yl)-n-(4-phenylthiazol-2-yl) acetamide derivatives useful in treatment of trpv1 related disorders |
| 05/18/2007 | CA2626483A1 Compounds and compositions as ppar modulators |
| 05/17/2007 | US20070112040 Amino nicotinate derivatives as glucokinase (GLK) modulators |
| 05/17/2007 | US20070112034 2-(benzimidazol-1-yl)-acetamide bisaryl derivatives |
| 05/17/2007 | US20070112011 Substituted 1-propiolylpiperazine compounds, their preparation and use |
| 05/17/2007 | US20070112000 Chemical compounds |
| 05/17/2007 | US20070111998 Novel heterocyclic compounds as pSTAT3/IL-6 inhibitors |
| 05/17/2007 | US20070111987 cyclization using phosphorus oxychloride; antipsychotic or neuroleptic agent for psychological disorders |
| 05/17/2007 | US20070111986 comprises the ring closure and deprotection of an intermediate; 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo[b,f]-1,4-thiazepine; used as an antipsychotic or neuroleptic |
| 05/16/2007 | EP1785420A1 Thiazole analogues and uses thereof |
| 05/16/2007 | EP1785134A2 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 05/16/2007 | EP1784400A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 05/16/2007 | EP1784390A2 Substituted benzofused heterocycles |
| 05/16/2007 | EP1784386A2 Histone deacetylase inhibitors |
| 05/16/2007 | EP1306373B1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 05/16/2007 | CN1964970A Iap的抑制剂 Iap inhibitors |
| 05/16/2007 | CN1964966A Rosiglitazone phosphate and polymorphic forms |
| 05/16/2007 | CN1964957A Anionic-sweetener-based ionic liquids and methods of use thereof |
| 05/16/2007 | CN1964956A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 05/16/2007 | CN1964946A 2-propylene-1-ones as hsp70 inducer |
| 05/16/2007 | CN1964944A Indole derivatives as antiviral agents |
| 05/16/2007 | CN1962641A Metalloproteinase inhibitors |
| 05/16/2007 | CN1315847C 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/16/2007 | CN1315822C Quinoline derivatives having VEGF inhibiting activity |
| 05/15/2007 | US7217826 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 05/15/2007 | US7217824 reacting, in the presence of a palladium catalyst and a first solvent a 4,7-dihalo-2,1,3-benzothiadiazole with a thienyl group adding reagent, producing comonomer for polyfluroenes used as semiconductors |
| 05/15/2007 | US7217716 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate NR2B antagonists |
| 05/15/2007 | US7217713 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
| 05/15/2007 | US7217712 4-Substituted-5-cyano-1H-pyrimidin-6-(thi)ones as GSK-3 inhibitors |
| 05/15/2007 | US7217706 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence |
| 05/15/2007 | CA2392973C Benzoimidazole derivatives useful as antiproliferative agents |
| 05/15/2007 | CA2366829C Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 05/15/2007 | CA2295087C Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 05/15/2007 | CA2155275C Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds |
| 05/10/2007 | WO2007053776A1 Pyrimidinyl-thiophene kinase modulators |
| 05/10/2007 | WO2007053765A2 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase |
| 05/10/2007 | WO2007053662A1 Dihydroisoindolones as allosteric modulators of glucokinase |
| 05/10/2007 | WO2007053657A1 Substituted pyrrolones as allosteric modulators of glucokinase |
| 05/10/2007 | WO2007053503A1 Substituted dihydroisoindolones as allosteric modulators of glucokinase |
| 05/10/2007 | WO2007053499A2 Compounds useful as antagonists of ccr2 |
| 05/10/2007 | WO2007053498A1 Compounds useful as antagonists of ccr2 |
| 05/10/2007 | WO2007053345A1 Glucokinase activators |
| 05/10/2007 | WO2007052882A1 Pyridine thiazole carboxamide derivatives, the preparation method thereof, and the composition for skin whitening containing the same |
| 05/10/2007 | WO2007052843A1 Heterocyclic amide compound and use thereof |
| 05/10/2007 | WO2007052794A1 o-SUBSTITUTED ANILINE DERIVATIVE AND ANTIOXIDANT DRUG |
| 05/10/2007 | WO2007051982A1 Triazole compounds as lipoxygenase inhibitors |
| 05/10/2007 | WO2007051846A1 Tricyclo substituted amides |
| 05/10/2007 | WO2007051845A1 Tricyclo substituted amides |
| 05/10/2007 | WO2007025897A3 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 05/10/2007 | WO2006120573A3 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors |
| 05/10/2007 | WO2006105081A3 Pharmacokinetically improved compounds |
| 05/10/2007 | WO2006016178A8 Enantioselective process |
| 05/10/2007 | US20070105926 Tetrazoyloxime derivative and agricultural chemical containing the same as active ingredient |
| 05/10/2007 | US20070105920 2-(Benzimidazol-1-Yl)-N-(4-phenylthiazol-2-yl) acetamide derivatives |
| 05/10/2007 | US20070105919 Thiazole derivatives |
| 05/10/2007 | US20070105908 Thiazolimine compound and oxazolimine compound |
| 05/10/2007 | US20070105907 Novel IDO inhibitors and methods of use thereof |
| 05/10/2007 | US20070105905 Novel macrocycles for the treatment of cancer |
| 05/10/2007 | US20070105899 Benzene compounds |
| 05/10/2007 | US20070105892 Amidino compounds as cysteine protease inhibitors |
| 05/10/2007 | US20070105871 1,3,4-Substituted pyrazoles as 5-ht receptor antagonists for the treatment of psychoses and neurological disorders |
| 05/10/2007 | US20070105866 5-lipoxygenase-activating protein (flap) inhibitors |
| 05/10/2007 | US20070105865 Substituted bicyclic quinazolin-4-ylamine derivatives |
| 05/10/2007 | US20070105862 Heat-shock protein binders |
| 05/10/2007 | US20070105858 Retinoic acid mimetic anilides |
| 05/10/2007 | US20070105854 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/10/2007 | US20070105852 Thiophene and furan compounds |
| 05/10/2007 | US20070105847 1,3-Dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes |
| 05/10/2007 | US20070105846 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 05/10/2007 | US20070105833 including cystic fibrosis transmembrane conductance regulator ("CFTR"), such as 4-amido-pyrimidine compounds and derivatives, used for treating genetic disorders; respiratory system disorders |
| 05/10/2007 | US20070105135 Charged compounds comprising a nucleic acid binding moiety and uses therefor |
| 05/10/2007 | CA2628486A1 Tricyclo substituted amides |
| 05/10/2007 | CA2628474A1 Pyrimidinyl-thiophene kinase modulators |
| 05/10/2007 | CA2628274A1 Glucokinase activators |
| 05/10/2007 | CA2628259A1 Dihydroisoindolones as allosteric modulators of glucokinase |
| 05/10/2007 | CA2628014A1 Ortho-substituted aniline derivative and antioxidant drug |
| 05/10/2007 | CA2627910A1 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase |
| 05/10/2007 | CA2627892A1 Substituted dihydroisoindolones as allosteric modulators of glucokinase |
| 05/10/2007 | CA2627813A1 Substituted pyrrolones as allosteric modulators of glucokinase |
| 05/10/2007 | CA2627516A1 Triazole compounds as lipoxygenase inhibitors |
| 05/10/2007 | CA2626475A1 Tricyclo substituted amides |
| 05/09/2007 | EP1783124A1 2-phenylthiophene derivative |
| 05/09/2007 | EP1781661A2 Vasopressin v1a antagonists |
| 05/09/2007 | EP1781650A1 Novel compounds having an anti-bacterial activity |
| 05/09/2007 | EP1781649A2 Substituted hydantoins |
| 05/09/2007 | EP1781648A2 1,3,4-oxadiazol-2-ones as ppar delta modulators |
| 05/09/2007 | EP1781647A2 Thiazole and isothiazole derivatives as protein kinase inhibitors |
| 05/09/2007 | EP1781646A1 Process for the preparation of 11-(4-[2-(2-hydroxyethoxy)ethyl]-i-piperazinyl)dibenzo[b,f][1,4]thiazepine |
| 05/09/2007 | EP1781633A1 Novel antidiabetic compounds |
| 05/09/2007 | EP1781619A1 Sigma receptor inhibitors |
| 05/09/2007 | EP1781613A1 Piperidine derivatives as histamine h3 receptor ligands |
| 05/09/2007 | EP1781606A2 Azetidine derivatives as ccr-3 receptor antagonists |
| 05/09/2007 | EP1680418B1 Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 05/09/2007 | EP1501796B1 3-(pyridinyl-amino)-1h-indole-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 05/09/2007 | EP1272477B1 Pyrimidine compounds |
| 05/09/2007 | EP1238970B9 Cycloamine ccr5 receptor antagonists |
| 05/09/2007 | EP1183245B1 Selective npy (y5) antagonists |